{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:59:07Z","timestamp":1788994747337,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["429965\/2018-4"],"award-info":[{"award-number":["429965\/2018-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.abd.2024.07.013","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:34:45Z","timestamp":1741797285000},"page":"456-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Psoriasis and cardiovascular risk: associated and protective factors"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2284-4111","authenticated-orcid":false,"given":"Luciana","family":"Agoglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7598-4361","authenticated-orcid":false,"given":"Helena","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4552-8453","authenticated-orcid":false,"given":"Ana Carolina","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0326-1225","authenticated-orcid":false,"given":"L\u00edvia","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9209-7863","authenticated-orcid":false,"given":"Cec\u00edlia S.X.L.","family":"Victer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7515-2365","authenticated-orcid":false,"given":"Sueli","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6318-7077","authenticated-orcid":false,"given":"Gil F.","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1355-2368","authenticated-orcid":false,"given":"Cristiane A.","family":"Villela-Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5817-9221","authenticated-orcid":false,"given":"Maria Chiara","family":"Chindamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2024.07.013_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.abd.2024.07.013_bib0010","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/BOR.0b013e3283031c99","article-title":"Psoriasis and metabolic disease: epidemiology and pathophysiology","volume":"20","author":"Azfar","year":"2008","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.abd.2024.07.013_bib0015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis","volume":"29","author":"Candia","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2024.07.013_bib0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2013EASD\u2013EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol."},{"key":"10.1016\/j.abd.2024.07.013_bib0025","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"J Hepatol."},{"key":"10.1016\/j.abd.2024.07.013_bib0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/rheumatology\/kep023","article-title":"Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy","volume":"48","author":"Lindsay","year":"2009","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.abd.2024.07.013_bib0035","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2022.12.034","article-title":"Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated","volume":"78","author":"Atallah","year":"2023","journal-title":"J Hepatol."},{"key":"10.1016\/j.abd.2024.07.013_bib0040","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/joim.13447","article-title":"The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast","volume":"291","author":"Arias de la Rosa","year":"2022","journal-title":"J Intern Med."},{"key":"10.1016\/j.abd.2024.07.013_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102891","article-title":"Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases","volume":"20","author":"Berger","year":"2021","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.abd.2024.07.013_bib0050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/ijms17040460","article-title":"NAFLD and increased aortic stiffness: parallel or common physiopathological mechanisms?","volume":"17","author":"Villela-Nogueira","year":"2016","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.abd.2024.07.013_bib0055","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/liv.12994","article-title":"Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio-T2DM cohort study","volume":"36","author":"Leite","year":"2016","journal-title":"Liver Int."},{"key":"10.1016\/j.abd.2024.07.013_bib0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.abd.2024.07.013_bib0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0399-8320(08)73994-0","article-title":"Transient elastography (FibroScan)","volume":"32","author":"de L\u00e9dinghen","year":"2008","journal-title":"Gastroent\u00e9rologie Clin Biol."},{"key":"10.1016\/j.abd.2024.07.013_bib0070","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1136\/gutjnl-2018-317334","article-title":"Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease","volume":"68","author":"Wong","year":"2019","journal-title":"Gut."},{"key":"10.1016\/j.abd.2024.07.013_bib0075","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol."},{"key":"10.1016\/j.abd.2024.07.013_bib0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","article-title":"Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity","volume":"30","author":"Van Bortel","year":"2012","journal-title":"J Hypertens."},{"key":"10.1016\/j.abd.2024.07.013_bib0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2013.10.023","article-title":"Subclinical cardiovascular disease in plaque psoriasis: association or causal link?","volume":"232","author":"Shaharyar","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.abd.2024.07.013_bib0090","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/diagnostics13111870","article-title":"Arterial stiffness as a surrogate marker of cardiovascular disease and atherosclerosis in patients with arthritides and connective tissue diseases: a literature review","volume":"13","author":"Triantafyllias","year":"2023","journal-title":"Diagnostics."},{"key":"10.1016\/j.abd.2024.07.013_bib0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000182256","article-title":"Chronic plaque psoriasis is associated with increased arterial stiffness","volume":"218","author":"Gisondi","year":"2009","journal-title":"Dermatology."},{"key":"10.1016\/j.abd.2024.07.013_bib0100","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00125-015-3658-9","article-title":"Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study","volume":"58","author":"Cardoso","year":"2015","journal-title":"Diabetologia."},{"key":"10.1016\/j.abd.2024.07.013_bib0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4330\/wjc.v8.i2.120","article-title":"Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: three different diseases on a unique background","volume":"8","author":"Ganzetti","year":"2016","journal-title":"World J Cardiol."},{"key":"10.1016\/j.abd.2024.07.013_bib0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ijms17020217","article-title":"Relationship between non-alcoholic fatty liver disease and psoriasis: a novel hepato-dermal axis?","volume":"17","author":"Mantovani","year":"2016","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.abd.2024.07.013_bib0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjd.16239","article-title":"Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?","volume":"179","author":"Prussick","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2024.07.013_bib0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.709396","article-title":"Aortic stiffness: epidemiology, risk factors, and relevant biomarkers","volume":"8","author":"Angoff","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.abd.2024.07.013_bib0125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10067-011-1892-1","article-title":"Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study","volume":"31","author":"Costa","year":"2012","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.abd.2024.07.013_bib0130","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/17512433.2021.1932461","article-title":"Methotrexate and cardiovascular risk in rheumatic diseases: a comprehensive review","volume":"14","author":"Verhoeven","year":"2021","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.abd.2024.07.013_bib0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997270","article-title":"Nonalcoholic fatty liver disease in inflammatory arthritis: relationship with cardiovascular risk","volume":"13","author":"Barbarroja","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.abd.2024.07.013_bib0140","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212557","article-title":"Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate","volume":"7","author":"Mangoni","year":"2018","journal-title":"Drugs Context."},{"key":"10.1016\/j.abd.2024.07.013_bib0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review","volume":"27","author":"Horreau","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2024.07.013_bib0150","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.abd.2024.07.013_bib0155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.abd.2024.07.013_bib0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2796.2012.02593.x","article-title":"Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti\u2010inflammatory drugs: a Danish real\u2010world cohort study","volume":"273","author":"Ahlehoff","year":"2013","journal-title":"J Intern Med."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059625000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:09:05Z","timestamp":1762301345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059625000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0365059625000212"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2024.07.013","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis and cardiovascular risk: associated and protective factors","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2024.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}